New York says it’s ready to embrace Testing for Treatment initiative

City vendors were eligible to order more than 20,088 courses of the two drugs and had over 14,386 courses in stock. Of this number, local facilities could order 13,968 courses of molnupiravir, and 12,013 courses were available at 11 facilities. For Paxlovid, city providers could order 6,120 courses and have 2,373 courses in six locations.

“We have enough supply to meet current demand and we are ready to get more when needed,” said Michael Lanza, a spokesman for the city. Department of Health and Mental Hygiene.

Asked about putting drugs in the hands of New Yorkers, Lanza pointed to a free same-day COVID drug home delivery program that launched in January and is run in partnership with Alto Pharmacy in Midtown. The company is the city’s exclusive supplier of antiviral pills until the supply increases enough to supply several partner pharmacies.

Availability of molnupiravir and paxlovid in Alto is much higher than elsewhere: as of March 2, there were 11,334 courses of molnupiravir and 2010 courses of paxlovid. The next nearest facility with a stockpile of this magnitude was NYU’s Sunset Terrace Family Health Center in Langone, which had only 400 courses of molnupiravir, and BronxCare Medical and Dental in Pau, which had 200 courses of Paxlovid.

“Our city’s public health system is seeing a decline in COVID-19 hospital admissions, but we remain very busy treating critically ill patients,” said Dr. Mitchell Katz, president and CEO of NYC Health + Hospitals, during the program’s launch. “Free home delivery of these antiviral pills will keep high-risk New Yorkers out of the hospital so we can free up critical resources immediately.”

This story first appeared in our sister publication, Crane’s business in New York.

Source link

Leave a Reply

Your email address will not be published.

Back to top button